ASH12 | MM - Case 1


A 42-year-old man is diagnosed with standard-risk IgG lambda multiple myeloma (MM) without bone involvement.

What would your initial systemic treatment likely be?

Assuming the patient has a very good partial response (VGPR) to treatment, how would you likely approach stem cell transplant outside a trial setting?

Do you believe the survival of your patients with MM and your ability to palliate the disease have changed over the past few years?